COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

2021290 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Rheumatology

Volume 3, Issue 6, pp. e419-e426

Field-Weighted Citation Impact: 17.63